CIS reduce the area in which the CRHR2 protein was expressed in the hippocampal CA1 region (P < 0.01), which was reversed by the XYS treatment (P < 0.01) (Figure 5Ba). The gene discussed is CRHR2; the disease is in situ carcinoma.